Skip to Main Content
Colorado Attorney General

Phil Weiser

Colorado Attorney General

File A Complaint
  • About Us
    • Attorney General Bio & Photos
    • Vision & Values
    • Senior Staff & Organization
    • Colorado Attorney General Annual Report
    • Attorney General Opinions
    • Budget & Accounting
    • Contact Our Office
  • Sections
    • Administration
    • Civil Litigation & Employment Law
    • Consumer Protection
    • Criminal Appeals
    • Criminal Justice
    • Natural Resources & Environment
    • Division of Community Engagement
    • Revenue & Regulatory Law
    • State Services
  • Careers
    • Attorney & Other Non-Classified Positions
    • Fellowships
    • Internships
    • Classified Staff Positions
    • Other Opportunities to Join our Team
  • Media Center
    • Press Room
    • Colorado Open Records Act – CORA
  • Resources
    • Survivors of Childhood Sexual Abuse
    • Victim Assistance
    • Data Protection Laws
    • Colorado Privacy Act
    • Funding Opportunities
    • Office of Financial Empowerment
    • Code of Colorado Regulations
    • Colorado Revised Statutes
    • Transparency Online Project (TOPS)
  • Licensing
    • Business Resources
    • Collection Agencies & Debt Collectors
    • Credit Services Organizations
    • UCCC Licensing & Notification
    • Debt Management Services Providers
    • Health Club Bonds
    • Repossessors
    • Student Loan Servicer Licensing
    • Telemarketing
  • Recursos en español

Attorney General Phil Weiser urges FDA to strengthen e-cigarette enforcement guidance to include menthol and disposable, refillable products

Feb. 27, 2020 (DENVER, Colo.)—Attorney General Phil Weiser today joined a bipartisan coalition of 27 attorneys general in sending a letter to the Food and Drug Administration (FDA) urging the agency to expand and strengthen its e-cigarette enforcement guidance by including menthol flavors and products that are not cartridge based.

“The current FDA guidance creates loopholes for menthol flavors and refillable devices that manufacturers can exploit.” said Weiser. “Colorado was one of the early states to open an investigation into e-cigarette manufacturer JUUL because of marketing practices directed at youth. We have one of the highest youth vaping rates in the country, and we’re addressing this critical issue from a number of directions, including raising public awareness about dangers of youth vaping, supporting policies to ban youth-friendly e-cigarette marketing and flavors, and exploring possible litigation.”

Under the guidance that the FDA issued in January, mint flavored e-cigarette products are included in the FDA’s enforcement priorities, and the coalition is urging the FDA to amend the guidance to include menthol flavors. The attorneys general point out that as a flavor derived from mint, menthol shares many of the same characteristics making it a convenient substitute for youths who would search for flavors to substitute for mint.

In addition to menthol serving as a likely mint substitute due to the flavor similarities, the coalition states that the FDA’s decision to permit menthol is problematic because the guidance does not explain how the FDA will distinguish between the two similar flavors. The coalition expresses concern that the FDA will be forced to rely on packaging descriptions of the flavors, which the attorneys general argue creates a loophole manufacturers can exploit by simply renaming the flavors on product labels.

Also in the comments, the coalition states that the FDA’s focus on cartridge-based products creates a loophole for self-contained, disposable products that are popular with youth. The coalition points out that with two of the most popular e-cigarette devices among high school students being disposable, the guidance will have the result of pushing youth toward refillable systems.

States that joined in signing the letter include: Arkansas, California, Connecticut, Colorado, Delaware, the District of Columbia, Hawaii, Idaho, Illinois, Maine, Maryland, Massachusetts, Nevada, New Mexico, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Texas, Utah, Virginia, Vermont, Washington, and Wisconsin.

###

Lawrence Pacheco
Director of Communications
(720) 508-6553
Lawrence.Pacheco@coag.gov

Attachments

Letter to the Food and Drug Administration

Most Recent

Attorney General Phil Weiser suit challenges federal attack on gender-affirming care

Dec. 24, 2025 (DENVER) — Attorney General Phil Weiser today joined a multistate coalition of states in filing a lawsuit to block an unlawful declaration from Health and Human Services Secretary Robert F. Kennedy, Jr. that threatens health care providers […]

Attorney General Phil Weiser sues Trump administration to defend important consumer protection efforts

Dec. 22, 2025 (DENVER) — Attorney General Phil Weiser today joined a coalition of attorneys general in suing the Trump administration to stop the complete defunding of the Consumer Financial Protection Bureau, or CFPB, which has returned more than $21 […]

Attorney General Phil Weiser announces $149.6M settlement with Mercedes-Benz and Daimler in emissions cheating case

Dec. 22, 2025 (DENVER) — Attorney General Phil Weiser today joined a bipartisan coalition of 50 attorneys general announcing a $149,673,750 settlement with Mercedes-Benz USA and Daimler AG for violating state laws prohibiting unfair or deceptive trade practices by marketing, […]

Office of the Attorney General
Colorado Department of Law
Ralph L. Carr Judicial Building
1300 Broadway, 10th Floor
Denver, CO 80203

(720) 508-6000

Contact the Office of the Attorney General

Contact

ACCESSIBILITY STATEMENT

DECLARACION DE ACCESIBILIDAD

Facebook
Twitter
LinkedIn
Instagram
YouTube
BlueSky